The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

4 Aug 2022 07:00

RNS Number : 8500U
Falanx Group Limited
04 August 2022
 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain

 

4 August 2022

 

FALANX GROUP LIMITED

(the "Company")

Trading Update

 

Falanx Group Limited (AIM: FLX), the AIM listed provider of cyber security services, is pleased to provide an update on its results for the year ended 31 March 2022 and the first quarter's trading to 30 June 2022.

 

Results for the Year Ended 31 March 2022 (continuing operations)

 

Revenues are expected to be c.£3.5m (2021: £3.1m) representing organic growth of c.14%, mainly arising from improved professional services revenues. The Company moved to a new cyber security monitoring platform (Triarii) during the year and this, combined with higher services utilisation, has increased the gross margin to c.40% (2021: c.32%). The Group expects to record a reduced adjusted EBITDA loss than in the previous year, despite having commenced an investment programme in the expansion of the cyber business following the disposal of the Assynt strategic intelligence divisions. The audit is very largely complete, no issues have been raised, and the audited results are expected to be announced in the middle of September 2022. 

 

Current Trading

 

The Group has been trading in line with management expectation since the start of the current financial year. Significant planned investment has taken place in the cyber division, particularly around sales and marketing expansion and product innovation. As a result of this, the business has established a far greater pipeline than in previous years. The pipeline is not only much larger in terms of financial value but also has a high level of advanced prospects and, most notably, the bulk of the pipeline now comprises recurring revenue opportunities for cyber security monitoring, including Triarii based on Microsoft Sentinel. Falanx continues to grow its channel business and has brought on dedicated resources to expand channel coverage. This investment has proved effective with new partners such as ESET, where opportunities have already been established for providing cyber security monitoring services to their MDR and EDR clients, as well as a much higher level of activity with longer standing partners.

 

New products have been launched for Continuous Vulnerability Scanning (CVS) and Retained Incident Response (R-IR) and these are expected to contribute to recurring revenues. These complement the previously launched Falanx: Cyber Exposure Level (f: CEL) tool which has been adopted by existing clients as well as creating a separate revenue opportunity with new customers.

 

Balance Sheet Position

 

At 30 June 2022, the Group had cash balances of £2.7m which were in line with budget. The Group has a normal working capital profile, HMRC legacy support around Covid-19 has been paid down save for a very small scheduled amount. The Board expects these cash balances to be sufficient for its organic growth plans.

 

Mike Read, CEO of Falanx, commented:

 

"We are very pleased with the Group's performance over the past few months which is benefiting from the focus on growing a pure play cyber security business. The recent investments in sales, marketing and new products has created a considerable pipeline of new business which is more significant than at any time in the Group's history. With a healthy balance sheet, we are able to focus on future growth and we are optimistic about outlook of the business."

 

Enquiries:

Falanx Group Limited

Alex Hambro Chairman

Mike Read CEO

Ian Selby CFO

Via IFC

WH Ireland Limited, Nomad and Broker

Mike Coe / Sarah Mather

 

+44 (0) 207 220 1666

 

IFC Advisory Ltd, Financial PR & IR

Graham Herring / Zach Cohen

+44 (0) 203 934 6630

 

 

About Falanx

Falanx Group Limited, is a cyber defence provider providing enterprise class defensive and offensive security solutions to SME. For further information: http://www.falanx.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSTTFIVIIF
Date   Source Headline
18th Jan 20212:00 pmRNSPrice Monitoring Extension
13th Jan 20214:41 pmRNSSecond Price Monitoring Extn
13th Jan 20214:35 pmRNSPrice Monitoring Extension
13th Jan 20212:05 pmRNSSecond Price Monitoring Extn
13th Jan 20212:00 pmRNSPrice Monitoring Extension
13th Jan 202111:06 amRNSSecond Price Monitoring Extn
13th Jan 202111:00 amRNSPrice Monitoring Extension
13th Jan 20217:00 amRNSTriarii to include Microsoft Azure Sentinel
18th Dec 20207:00 amRNSUpdate on SolarWinds® Orion® Platform Cyberattack
17th Dec 20202:28 pmRNSResult of AGM
17th Dec 20207:00 amRNSInterim results
1st Dec 20207:00 amRNSTotal Voting Rights
23rd Nov 202010:12 amRNSNotice of AGM
4th Nov 20204:42 pmRNSDirector subscriptions/PDMR dealing and TVR
30th Oct 20204:17 pmRNSPublication of final results & total voting rights
30th Oct 20207:00 amRNSPreliminary results for year ended 31 March 2020
28th Oct 20207:00 amRNSFalanx joins SolarWinds TAP
2nd Oct 20201:53 pmRNSHolding(s) in Company
1st Oct 20202:28 pmRNSHolding(s) in Company
1st Oct 20202:21 pmRNSHolding(s) in Company
29th Sep 20207:00 amRNSConfirmation of successful fundraising
28th Sep 20204:55 pmRNSProposed Equity Fundraise
18th Sep 20207:00 amRNSStrategic Contract Win
21st Aug 202012:16 pmRNSDirector/PDMR Shareholding
17th Aug 20207:00 amRNSStrategic Contract Win
5th Aug 20207:00 amRNSTrading Statement
24th Jul 20207:00 amRNSHolding(s) in Company
24th Jul 20207:00 amRNSHolding(s) in Company
9th Jul 20202:19 pmRNSHolding(s) in Company
21st Apr 20207:00 amRNSSalary sacrifice, grant of options & PDMR dealing
27th Feb 202011:56 amRNSHolding(s) in Company
2nd Jan 20203:21 pmRNSDirector/PDMR Shareholding
20th Dec 20197:00 amRNSSale of Furnace and Directorate Change
3rd Dec 20194:40 pmRNSResult of AGM
3rd Dec 20197:00 amRNSInterim Results
22nd Nov 201910:18 amRNSHolding(s) in Company
11th Nov 20197:00 amRNSTrading update, notice of results & notice of AGM
25th Sep 20197:30 amRNSGrant of Share Options
25th Sep 20197:00 amRNSDirector/PDMR Shareholding
24th Sep 201911:37 amRNSDirector/PDMR Shareholding
23rd Sep 20193:13 pmRNSAvailability of report and accounts
19th Sep 20197:00 amRNSAnnual results for the year ended 31 March 2019
31st May 201911:39 amRNSDirector/PDMR Shareholding
29th May 20197:00 amRNSChange of Adviser
28th Mar 20197:00 amRNSDirectorate Change
22nd Mar 20197:00 amRNSChange of Adviser
18th Feb 201910:32 amRNSDirector / PDMR Shareholding
18th Feb 201910:18 amRNSDirector / PDMR Shareholding
21st Dec 20181:01 pmRNSGrant of Share Options
21st Dec 201812:47 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.